ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625731 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625731; 2) Community: the network communities that were significantly associated with the response to NSC 625731; 3) Molecule: the relationships between components within communities and NSC 625731; 4) MDR: the compounds that were significantly associated with the NSC 625731.

NSC Compound Enrichment Correlation
NSC 712734 Null 0.00433056621075582 -0.24847444
NSC 719177 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, 1-adamantaneethyl ester 0.00433056621075582 0.47724791
NSC 722341 2-(3'-Hydroxy-3'-methylbut-1'-ynyl)-4,6-di-(4''-methoxypheno xy)-1,3,5-triazine 0.00433056621075582 0.53390322
NSC 728220 1-(3-Bromo-phenyl)-3-(pyridin-2-ylsulfanyl)-propenone 0.00433056621075582 0.50649201
NSC 741942 Null 0.00433056621075582 0.332744
NSC 125347 Null 0.00433056621075587 0.29997658
NSC 136468 Null 0.00433056621075587 0.46115258
NSC 254677 Phomazarin 0.00433056621075587 -0.21501794
NSC 290193 CYCLOSPORIN A 0.00433056621075587 0.40555691
NSC 348121 4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- 0.00433056621075587 0.36143028
Total:89  Current:15    [First] [Prev] [Next] [Last]